Sort
10,766 grants matching “checkpoint inhibitor”
Combination of tumor targeted therapy with stroma modulating agent for PDAC
$93,548Ketankumar D. Patel · St. John'S University · R16 · FY2024 · GM
Signaling and Biotechology Program
$93,518Hui-Kuan Lin · Wake Forest University Health Sciences · P30 · FY2019 · CA
Identification of first-in-class epigenetic inhibitors that target Thymine DNA Glycosylase (TDG) for future precision therapy of metastatic melanoma
$93,500Alfonso Bellacosa · Research Inst Of Fox Chase Can Ctr · R03 · FY2021 · CA
Identification of first-in-class epigenetic inhibitors that target Thymine DNA Glycosylase (TDG) for future precision therapy of metastatic melanoma
$93,500Alfonso Bellacosa · Research Inst Of Fox Chase Can Ctr · R03 · FY2022 · CA
Mechanism of estrogen independent proliferation in ER+ breast cancer cells
$93,333Andrea Hope Bild · Beckman Research Institute/City Of Hope · U01 · FY2025 · CA
Genome Integrity Through the Cell Cycle in Homeostasis and Cancer
$93,312Zachary Kenneth Mirman · Brigham And Women'S Hospital · K00 · FY2022 · CA
Leveraging gnotobiotic models to study the gut microbiota and anti-tumor immunity
$93,263Jessica Lynn Fessler · Stanford University · K00 · FY2022 · CA
Developmental Therapeutics Research Program
$93,151John James Letterio · Case Western Reserve University · P30 · FY2024 · CA
Developmental Therapeutics Research Program
$93,151John James Letterio · Case Western Reserve University · P30 · FY2023 · CA
Musculoskeletal Pain Among Breast Cancer Survivors: Through Bio-behavioral and Imaging Lenses
$93,096Yehui Zhu · Massachusetts General Hospital · K00 · FY2020 · CA
Poly-Nucleic acid complexes for chemokine modulation of the tumor microenvironment
$92,882Jacob Daggett Ramsey · Duke University · K00 · FY2025 · CA
Targeting TERT in Melanoma
$92,585Jessie Villanueva · Wistar Institute · R01 · FY2019 · CA
Enabling technologies to study how mechanics influence T cell function at the molecular and cellular levels
$92,340Pui-Yan Victor Ma · Brigham And Women'S Hospital · K00 · FY2020 · CA
Molecular mechanisms of genome maintenance during DNA replication and repair
$92,233Kamakoti P. Bhat · Stanford University · K00 · FY2020 · CA
Lung Cancer
$92,233A. McGarry Houghton · Fred Hutchinson Cancer Center · P30 · FY2025 · CA
The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer
$91,595Evanthia Theodosiou Roussos Torres · University Of Southern California · P20 · FY2025 · CA
Immune Checkpoints for Intestinal Innate Lymphoid Cells
$91,500Jennifer Kaoru Bando · Washington University · K99 · FY2019 · DK
Mechanism of estrogen independent proliferation in ER+ breast cancer cells
$91,465Aritro Nath · Beckman Research Institute/City Of Hope · U01 · FY2023 · CA
Mechanism of estrogen independent proliferation in ER+ breast cancer cells
$91,465Aritro Nath · Beckman Research Institute/City Of Hope · U01 · FY2023 · CA
Regulation of Renal Progenitor Cells in Regenerating Kidneys
$91,100Neil A Hukriede · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · DK
Identifying Genetic Drivers of the Immunosuppressive Tumor Microenvironment in Lung Cancer
$90,746Gurkan Mollaoglu · Icahn School Of Medicine At Mount Sinai · K00 · FY2020 · CA
Radioimmunotherapy Combinations for B-cell Malignancy
$90,678Damian J. Green · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics
$90,477Amarnath Natarajan · University Of Nebraska Medical Center · R01 · FY2010 · CA
Leveraging gnotobiotic models to study the gut microbiota and anti-tumor immunity
$90,425Jessica Lynn Fessler · Stanford University · K00 · FY2021 · CA
Functional Analysis of p53 Polymorphic Variants
$90,413Maureen E Murphy · Wistar Institute · R01 · FY2024 · CA